Nathan Bahary
Papers
1
Total Citations
57
H-Index
1
About
Nathan Bahary is a leading clinical researcher in gastrointestinal oncology, with a particular focus on pancreatic cancer. His work has significantly advanced the role of stereotactic body radiotherapy (SBRT) in the management of pancreatic adenocarcinoma, especially in the challenging postoperative setting. His most-cited study, "Adjuvant Stereotactic Body Radiotherapy for Resected Pancreatic Adenocarcinoma with Close or Positive Margins" (2010, 57 citations), established a critical proof-of-concept for using SBRT to improve local control in patients with high-risk margins after surgery. This contribution helped shape modern adjuvant treatment paradigms, offering a more precise and potentially less toxic alternative to conventional radiation. Beyond this landmark paper, Dr. Bahary’s research portfolio spans clinical trials, biomarker discovery, and the integration of novel systemic therapies with radiation. His work is widely cited by peers and has influenced national treatment guidelines. For students and researchers, Dr. Bahary exemplifies how focused, clinically relevant research can directly impact patient outcomes in one of oncology’s most difficult disease sites.
Research Focus
Key Achievements
Top Papers
- 1